Five-year summary

Consolidated income statement

Revenue

4.5

8.4

14.1

25.2

31.2

% gross profit to sales

67%

77%

77%

83%

88%

Research and development expenses

(8.7)

(12.4)

(17.0)

(29.7)

(32.3)

Other administrative expenses

(2.2)

(1.8)

(2.6)

(3.0)

(3.2)

Amortisation

(1.0)

–

(2.0)

(10.2)

(10.2)

Share-based compensation

(0.6)

(0.7)

(1.6)

(2.7)

(1.9)

Share of loss of associate

–

–

(0.2)

(0.3)

(0.6)

Operating loss

(9.6)

(8.5)

(11.2)

(25.1)

(20.9)

Investment income

0.8

1.0

2.8

4.5

3.6

Finance costs

(0.2)

–

(0.1)

(0.8)

(2.3)

Loss after taxation

(7.8)

(6.5)

(7.1)

(19.2)

(16.7)

Consolidated cash flow statement

Net cash outflow from operations

(6.2)

(2.5)

(7.9)

(3.7)

(3.6)

Net taxes received

1.2

1.0

1.4

2.2

2.9

Interest received

0.8

1.0

2.8

4.5

3.6

Net capital expenditure

(0.5)

(1.3)

(2.4)

0.6

(1.6)

Net cash acquired with Innovata acquisition

–

–

17.1

–

–

Consolidated balance sheet

Cash and cash equivalents

18.4

16.8

77.0

78.8

74.0

Shareholders’ equity

22.0

16.6

182.0

169.5

154.9